Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Hirata

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Arthritis Research & Therapy|April 17, 2015
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registryRyoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Internal Medicine (Tokyo, Japan)|May 1, 2024
A Preliminary Survey of Rheumatologists on the Management of Late-onset Rheumatoid Arthritis in JapanSatoshi Takanashi, Yuko Kaneko, Yutaka Kawahito, et al.
Scientific Reports|July 8, 2018
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre studyMirei Shirakashi, Hajime Yoshifuji, Yuzo Kodama, et al.
Modern Rheumatology|January 7, 2020
2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseasesYoshiya Tanaka, Masataka Kuwana, Takao Fujii, et al.
BMC Rheumatology|December 25, 2022
Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and designMasayo Kojima, Yutaka Kawahito, Takahiko Sugihara, et al.
Modern Rheumatology|November 21, 2013
Primary and secondary surveys on epidemiology of Sjögren's syndrome in JapanHiroto Tsuboi, Hiromitsu Asashima, Chinatsu Takai, et al.
Scientific Reports|November 13, 2020
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patientsDaihei Kida, Nobunori Takahashi, Atsushi Kaneko, et al.
Modern Rheumatology|May 23, 2019
Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RDTakuji Nakamura, Tomomi Satoh-Nakamura, Akio Nakajima, et al.
Research Square|March 16, 2022
Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19Shohei Eto, Yoko Nukui, Miyuki Tsumura, et al.
Journal of Clinical Immunology|June 28, 2022
Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19Shohei Eto, Yoko Nukui, Miyuki Tsumura, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Arthritis Research & Therapy|April 17, 2015
Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registryRyoko Sakai, Soo-Kyung Cho, Toshihiro Nanki, et al.
Internal Medicine (Tokyo, Japan)|May 1, 2024
A Preliminary Survey of Rheumatologists on the Management of Late-onset Rheumatoid Arthritis in JapanSatoshi Takanashi, Yuko Kaneko, Yutaka Kawahito, et al.
Scientific Reports|July 8, 2018
Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre studyMirei Shirakashi, Hajime Yoshifuji, Yuzo Kodama, et al.
Modern Rheumatology|January 7, 2020
2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseasesYoshiya Tanaka, Masataka Kuwana, Takao Fujii, et al.
BMC Rheumatology|December 25, 2022
Late-onset rheumatoid arthritis registry study, LORIS study: study protocol and designMasayo Kojima, Yutaka Kawahito, Takahiko Sugihara, et al.
Modern Rheumatology|November 21, 2013
Primary and secondary surveys on epidemiology of Sjögren's syndrome in JapanHiroto Tsuboi, Hiromitsu Asashima, Chinatsu Takai, et al.
Scientific Reports|November 13, 2020
A retrospective analysis of the relationship between anti-cyclic citrullinated peptide antibody and the effectiveness of abatacept in rheumatoid arthritis patientsDaihei Kida, Nobunori Takahashi, Atsushi Kaneko, et al.
Modern Rheumatology|May 23, 2019
Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RDTakuji Nakamura, Tomomi Satoh-Nakamura, Akio Nakajima, et al.
Research Square|March 16, 2022
Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19Shohei Eto, Yoko Nukui, Miyuki Tsumura, et al.
Journal of Clinical Immunology|June 28, 2022
Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19Shohei Eto, Yoko Nukui, Miyuki Tsumura, et al.
Pageof 16